Search
Abstract & Clinical Case Submission and Travel Grant
Submit your abstract here
Abstract and clinical case procedurePlease note that the submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session at the time…
Selected EMA news
November 2024New medicines recommended for approval
Eltrombopag Viatris (eltrombopag) – generic
Treatment of primary immune thrombocytopenia and thrombocytopenia associated with chronic hepatitis C (disease in which patients have low levels of blood platelets)
Alhemo (concizumab)
Prevention of bleeding in patients with hemophilia A…
European Hematology Curriculum
Harmonization of hematology knowledge is part of EHA’s mission. The first step in harmonizing hematology training is to stipulate the required fields of knowledge, each with its recommended level of competence.
Read moreEHA-HKSH Hematology Tutorial
EHA is joining the Hong Kong Society of Hematology (HKSH) to organize the EHA-HKSH Hematology Tutorial on Lymphoid Malignancies.
Read moreResearch
Research in hematology has dramatically improved our understanding of hematologic diseases and resulted in many innovative, groundbreaking discoveries.
Read moreRegistration
Register here
Individual registrationHybrid registration includes:
In-person access to the scientific and educational sessions of the meeting
Meeting materials
Coffee/tea breaks on February 6-8, 2025 and lunches on February 7-8, 2025
Access to the Welcome Reception
Access to the Poster Session(s) and viewing of the physical…
Lighting the Flame program phases
A full guide to what our Lighting the Flame program involves, including dates of upcoming online workshops and in-person retreats.
Read moreAbstract & Clinical Case Submission
Abstract submission is an important part of the 7th European CAR T-cell Meeting.
Read moreTravel Grants
Travel grant application is now closed. Travel grants are intended to support young investigators to participate in the 7th European CAR T-cell Meeting; therefore, applicants should be 40 years of age or younger.
Read more